Idoyaga Lab
@idoyagalab.bsky.social
1.4K followers 380 following 23 posts
Laboratory of Dendritic Cell Immunobiology at The University of California, San Diego
Posts Media Videos Starter Packs
Pinned
idoyagalab.bsky.social
Our paper made the cover of Nature Immunology’s September issue! 🎉
Aren’t dendritic cells beautiful? 😍
SEM shows pDCs as they switch identity into cDC2-like cells.
Congrats to the whole team! 👏
🔗 www.nature.com/ni/volumes/2...
Reposted by Idoyaga Lab
profandrewmac.bsky.social
Beautiful data from Franca Ronchese, all the way from @malaghan.bsky.social in New Zealand, about generation and function of subsets of skin #DendriticCells in #allergic responses #EMDS2025
Reposted by Idoyaga Lab
profandrewmac.bsky.social
A fascinating education in #LangerhansCell biology and function from Clare Bennett, as well as a closing advert for the 18th International #DendriticCell symposium in San Diego next year #EMDS2025 #DC2026
Reposted by Idoyaga Lab
jem.org
Tadepalli, Clements et al. @idoyagalab.bsky.social reveal that CD301b⁺ monocyte-derived dendritic cells mediate resistance to #radiotherapy. rupress.org/jem/article/...

📘 #Macrophages and #DendriticCells in Health and Disease 👉 rupress.org/jem/collecti...
idoyagalab.bsky.social
Thank you so much Hiu!! 🙏
idoyagalab.bsky.social
Thanks 🙏 Michael!!
idoyagalab.bsky.social
Gracias Miguel! 🙏
idoyagalab.bsky.social
Thank you Caetano! 🙏
idoyagalab.bsky.social
Our paper made the cover of Nature Immunology’s September issue! 🎉
Aren’t dendritic cells beautiful? 😍
SEM shows pDCs as they switch identity into cDC2-like cells.
Congrats to the whole team! 👏
🔗 www.nature.com/ni/volumes/2...
Reposted by Idoyaga Lab
rebecaarroyo.bsky.social
Thanks to @idoyagalab.bsky.social for supporting my postdoctoral work and making this paper possible. Super excited to show how pDCs regulate their antigen presentation function switching to cDC2!
idoyagalab.bsky.social
Delighted to share that our @natimmunol.nature.com paper has now a fantastic News & Views
🔗 www.nature.com/articles/s41...
Thank you, @esegura-lab.bsky.social, for a clear and thoughtful summary 🙏

And thanks to our 3 amazing reviewers: your feedback made this work stronger. Peer review at its best!
idoyagalab.bsky.social
Why it matters:
This pDC → cDC plasticity could let us tune immunity — boosting antiviral defenses or damping harmful inflammation in autoimmunity.

A new lever for immune therapy?
idoyagalab.bsky.social
This isn’t just in a petri dish:
We saw it in human skin inflammation, wounds, and even healthy aging.
pDC plasticity happens in vivo — actively shaping immune responses in health & disease.
idoyagalab.bsky.social
Using single-cell omics + functional assays, we saw activated pDCs lose IFN-I machinery & gain cDC type 2 (cDC2) traits— a full fate switch.

Two key regulators:

TNF → is the switch push
IFN-I → is the restrain
idoyagalab.bsky.social
pDCs are famous for cranking out type I interferon to fight viruses.
Conventional DCs (cDCs) present antigens to activate T cells.
But here’s the puzzle: why are pDCs part of the dendritic cell family at all? 🤔
Turns out, they can change teams.
Reposted by Idoyaga Lab
klechevskylab.bsky.social
Langerhans Cells, Dendritic Cell and #skinimmunology lovers❤️ #LC2025 registration is NOW OPEN! Meet us in St. Louis @washu_pathology, Sep. 3-5, 2025, Amazing program! Intimate and collaborative discussions on breakthrough discoveries! register today at langerhans.org
idoyagalab.bsky.social
Our latest @jem.org paper is out!
Radiotherapy induces GM-CSF in melanoma, driving monocytes to become regulatory monocyte-derived dendritic cells (moDCs)—traced with Ms4a3-TdTomato mice!
Huge shoutout to @Sirimuvva Tadepalli + @Derek Clements for leading this!
jem.org
#Radiotherapy not only kills tumors but also shapes #immunity. @idoyagalab.bsky.social reveal that in radioresistant tumors, clinically relevant radiotherapy induces GM-CSF secretion, driving immunosuppressive monocyte-derived dendritic cells and regulatory T cells. rupress.org/jem/article/...
Reposted by Idoyaga Lab
shalinhnaik.bsky.social
We are ramping up our attempts to get DC1 immunotherapy into the clinic for colorectal and lung cancer. Here me talk about why DC1s are the right choice, and how
WEHI and PeterMacCC will get it to clinical trial within 2 yrs. Start ~13 min in. podcasts.apple.com/au/podcast/v...
VAXXED: Game on, with BASE and WEHI
Podcast Episode · Phase III · 19/11/2024 · 26m
podcasts.apple.com